Alejandro Gru, MD
Dermatopathology · New York, NYNPI 1689899817
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $172,689 of the $241,682 with a category attached, or 71.5%. 6 manufacturers reported payments, led by Stemline Therapeutics Inc. at 59.7% of the total. Among dermatopathology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $1473.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stemline Therapeutics Inc.$144K
- Blueprint Medicines Corporation$41K
- Kyowa Kirin, Inc.$30K
- Sanofi US Services Inc.$14K
- Innate Pharma, Inc$7K
- Seagen Inc.$5K
Across 3 payments — averaging $9332.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stemline Therapeutics Inc.$15K
- Innate Pharma, Inc$7K
- Seagen Inc.$6K
What the payments were for
- Consulting fees$48,62920%
- Speaking & faculty fees$172,68971%
- Travel & lodging$17,4887%
- Food & beverage$2,8181%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stemline Therapeutics Inc. | 102 | $144,345 |
| Blueprint Medicines Corporation | 26 | $40,617 |
| Kyowa Kirin, Inc. | 24 | $29,687 |
| Sanofi US Services Inc. | 3 | $14,169 |
| Innate Pharma, Inc | 1 | $7,424 |
| Seagen Inc. | 8 | $5,440 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$241,682 in reported general payments places this provider in the 95th percentile of 44 dermatopathology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatopathology in New York
- Jisun ChaNew York$756
- Adam RubinNew York$264
- Erika BalfourNew York$211
- Cynthia KucherNew York$193
- Robert PhelpsNew York$152
- Melissa PulitzerNew York$108
- Chen ChenNew York$91
- George NiedtNew York$82
- Shane MeehanNew York$76
- David SilversNew York$52
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.